Condition
Lymphoid Hematological Malignancies clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Lymphoid Hematological Malignancies clinical trials that are recruiting, at sites in 2 countries (most in Switzerland (1), China (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Dynamic individualized risk profiling for patients receiving CD19 CAR T-cell therapy
This project tries a combined blood, imaging, and lab test to predict which adults with relapsed or refractory B‑cell lymphoma will do well after CD19 CAR T‑cell therapy.
-
CD20/CD22 targeted CAR T-cell therapy for blood cancers
This study is testing a new CAR T-cell therapy that targets specific proteins on blood cancer cells to see if it can help patients whose cancer hasn't responded to other treatments.
Related topics
Quick answers
How many Lymphoid Hematological Malignancies clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Switzerland (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.